Status

Current conditions ICD-9-CM:
2003
225.0 BENIGN NEOPLASM OF BRAIN
345.90 UNSPECIFIED EPILEPSY WITHOUT MENTION OF INTRACTABLE EPILEPSY
2010
225.0 BENIGN NEOPLASM OF BRAIN
345.90 UNSPECIFIED EPILEPSY WITHOUT MENTION OF INTRACTABLE EPILEPSY
2012
225.0 BENIGN NEOPLASM OF BRAIN
345.90 UNSPECIFIED EPILEPSY WITHOUT MENTION OF INTRACTABLE EPILEPSY
375.15 TEAR FILM INSUFFICIENCY,UNSPECIFIED
367.89 OTHER DISORDERS OF REFRACTION AND ACCOMMODATION
377.61 ASSOCIATED WITH NEOPLASMS
729.1 MYALGIA AND MYOSITIS, UNSPECIFIED
719.39 PALINDROMIC RHEUMATISM,MULTIPLE SITES
680.0 CARBUNCLE AND FURUNCLE, FACE
378.41 ESOPHORIA
311 DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED
523.8 OTHER PERIODONTAL DISEASES(PERIODONTAL POCKET,GINGIVAL POLYP)
681.02 ONYCHIA AND PARONYCHIA OF FINGER
2013
225.0 BENIGN NEOPLASM OF BRAIN
345.90 UNSPECIFIED EPILEPSY WITHOUT MENTION OF INTRACTABLE EPILEPSY
704.8 OTHER DISEASES OF HAIR AND HAIR FOLLICLES
706.1 OTHER ACNE
444.22 ARTERIAL EMBOLISM AND THROMBOSIS OF LOWER EXTREMITY
375.15 TEAR FILM INSUFFICIENCY,UNSPECIFIED
367.89 OTHER DISORDERS OF REFRACTION AND ACCOMMODATION
377.61 ASSOCIATED WITH NEOPLASMS
378.41 ESOPHORIA
728.85 (728.850) SPASM OF MUSCLE
353.4 LUMBOSACRAL ROOT LESIONS,NOT ELSEWHERE CLASSIFIED
780.52 (780.520) OTHER INSOMNIA
788.43 NOCTURIA
2014
225.0 BENIGN NEOPLASM OF BRAIN
345.90 UNSPECIFIED EPILEPSY WITHOUT MENTION OF INTRACTABLE EPILEPSY
374.05 TRICHIASIS WITHOUT ENTROPION
372.72 CONJUNCTIVAL HEMORRHAGE
375.15 TEAR FILM INSUFFICIENCY,UNSPECIFIED
367.89 OTHER DISORDERS OF REFRACTION AND ACCOMMODATION
377.61 ASSOCIATED WITH NEOPLASMS
378.41 ESOPHORIA
2015
225.0 BENIGN NEOPLASM OF BRAIN
345.90 UNSPECIFIED EPILEPSY WITHOUT MENTION OF INTRACTABLE EPILEPSY
705.83 HIDRADENITIS
698.8 OTHER PRURITIC CONDITIONS
686.9 UNSPECIFIED LOCAL INFECTIONS OF SKIN AND SUBCUTANEOUS TISSUE
686.09 OTHER PYODERMA
272.0 PURE HYPERCHOLESTEROLAEMIA (FAMILIAL HYPERCHOLESTESTEROLEMIA)
729.1 MYALGIA AND MYOSITIS, UNSPECIFIED
719.39 PALINDROMIC RHEUMATISM,MULTIPLE SITES
377.61 ASSOCIATED WITH NEOPLASMS
311 DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED
307.48 REPETITIVE INTRUSIONS OF SLEEP
705.81 DYSHIDROSIS
372.72 CONJUNCTIVAL HEMORRHAGE
680.2 CARBUNCLE AND FURUNCLE, TRUNK
523.3 ACUTE PERIODONTITIS(ACUTE PERICORONITIS)
Current conditions ICD-10-CM:
2016

E780 Pure hypercholesterolemia
G40.909 Epilepsy, unspecified, not intractable, without status epilepticus
L301 Dyshidrosis [pompholyx]
F32.9 Major depressive disorder, single episode, unspecified
D33.2 Benign neoplasm of brain, unspecified
H04.123 Dry eye syndrome of bilateral lacrimal glands
H47.529 Disorders of visual pathways in (due to) neoplasm, unspecified side
H02.052 Trichiasis without entropian right lower eyelid
H11.31 Conjunctival hemorrhage, right eye
H52.6 Other disorders of refraction
H50.51 Esophoria
H02.055 Trichiasis without entropian left lower eyelid
H47.099 Other disorders of optic nerve, not elsewhere classified, unspecified eye
F51.8 Other sleep disorders not due to a substance or known physiological condition
G40.901 Epilepsy, unspecified, not intractable, with status epilepticus
L0881 Pyoderma vegetans
B009 Herpesviral infection, unspecified
J069 Acute upper respiratory infection, unspecified
M79.1 Myalgia
M12.39 Palindromic rheumatism, multiple sites

Current treatment centers:
GP/ The department of Neurosurgical emergency & Critical Care of Chang Gung Memorial Hospital Linkou Branch/ TCM oncology of China Medical University Hospital Cancer Center/ and Taichung Hospital, Ministry of Health and Welfare

Contents of reference sources:
MIMS- Search drug information/ interaction/ images & medical diagnosis.
Complementary and Alternative Healing University- Dictionary of Chinese Herbs. http://alternativehealing.org
Database 醫砭‧沈藥子 http://yibian.hopto.org
Traditional Chinese Medicine (TCM) Wiki http://www.tcmwiki.com/

Tuesday, December 4, 2012

mo yao沒藥

Pharmaceutical name英文藥名﹕Myrrha
Botanical name學名﹕Commiphora molmol, Engi/ Balsamodendron Myrrha/ Commiphora Myrrha/ Commiphora abyssinica Engl.
Other Names別名﹕mo yao 末藥 (written differently in the first character)
【處方名】 :沒藥,末藥,制沒藥,炙沒藥,醋炒沒藥,明沒藥,生沒藥,生明沒藥。 處方中寫沒藥,末藥均指生沒藥。
Common Name英文名﹕myrrh
Distribution產地﹕north eastern Africa and Middle East
Properties(characteristics)性味﹕
bitter, neutral
味苦,性平
Channels (meridians) entered歸經﹕
liver, spleen, heart
入肝,脾,心 ,腎經。
①《本草經疏》:“入足厥陰經。”②《本草新編》:“入 脾,腎二經。”③《本草求真》:“入心,肝。”
Medical functions藥理﹕
1. inhibits pain
2. antibiotic
3. reduce swelling (detumescent )
4. wound healing
1. 鎮痛
2. 抑菌
3. 消腫
4. 療傷口
Actions & Indications主治﹕
For pain due to injuries, bruises, rheumatoid arthritis, tumors in the uterus, hemorrhoid,  cataract, amenorrhea , bone and muscle ache﹐  angina pectoris.
External use on inflammation of the mouth cavity, periodontitis,wounds from cut not healing, and pharyngitis.
有活血止痛,消 腫生肌的功能。
治跌打損傷, 瘀痛, 金瘡,筋骨, 心腹諸痛, 風濕痹 痛,症 瘕,經閉, 痈疽肿痛, 痔漏, 目障, 或 氣滞血瘀的心胸悶痛。
外用於瘡瘍腫痛或潰破久不收口, 口腔炎,牙齦炎,咽炎 。
Chemical ingredients化學成份﹕
Contains 2.5% to 9% of volatile oil, 25% to 35% of resin, 57% - 65% of gum, water and other impurities about 3 to 4%. In top quality mo yao (myrrh), the part that is not soluble in alcohol should not exceed 70% and ash should not exceed 5%. Because mo yao comes from different sources, the ingredients can be slightly different.
主要含2.5%~9%的揮發油,25%~35%的樹脂,57%~65%的膠等成分,此外為水分及各種雜質約3~4%。上等沒藥的醇不溶性成分不超過70%;灰分不超5%。沒藥成分可因來源不同而稍有差異。
α -,β-Heerabomyrrholic acid/α -,β- 罕沒藥酸
α -,β- γ-Commiphoric acid/α -,β- γ-沒 藥酸
Commiphorinic acid/沒藥尼酸
α -,β-Heerabomyrrhol/α -,β-罕沒藥酚
Heeraboresene/罕沒藥樹脂
Commiferin/沒藥萜醇
myrrholic acid/沒藥酸
methanoic acid (formic acid)/甲酸
acetic acid/乙酸 (醋酸)
oxidase/氧化酶
Eugenol/丁香油酚; (丁香酚) (揮發油)
m-Cresol/間苯甲酚
Cumin aldehyde/枯醛
Pine-ne/蒎烯
Dipentene/二戊烯
Limonene/檸檬烯
Cinnamic aldehyde/桂皮醛
Heerabolene/罕沒藥烯
間甲基酚(揮發油)
cuminaldehyde/枯茗醛
cinnamaldehyde/桂皮醛
formic acid ester/甲酸酯
acetic acid ester/乙酸酯
ester of myrrholic acid/沒藥酸酯
heerabolene/罕沒藥烯
α-,β-bisabolene/α 及β-沒藥烯
dl-limonene/dl-苧烯
myrrhin/沒藥樹脂
After heating, the following were obtained加熱得沒藥脂酸類:
α-,β-, γ-commiphoric acid/α-,β-,γ-沒藥脂酸
com-miphorinic acid/次沒藥脂酸
α -,β-heerabomyrrholic acid/α-,β-罕沒藥脂酸
α-heerabomyrrhol/α-罕沒藥脂酚
β-heer-abomyrrhol/β-罕沒藥脂酚
protocatechuic acid/原兒茶酸
catechol/兒茶酚
heeraboresene/罕沒藥氧化樹脂
gum arabic/阿拉伯樹膠
After hydrolysis, the following were obtained水解得:
arabinoxylan/阿拉伯聚糖
xylans/木聚糖
galactan, galactosan/半乳 聚糖
Dosage用量﹕
For decoction: 3 to 9 g.
For external use: use appropriate amount. Grind into powder and make into paste and apply to affected areas.
內服入煎劑﹕ 3~9克。
外用:適量﹐研末調敷。
Samples of formulae處方舉例﹕
Combination:
1. combine with ru xiang: rids of blood stasis, loosens tight tendons.
2. combine with chuan shan jia: lessens swelling and pain; rids of blood stasis.
3. combine with xue jie: lessens pain and rids of blood stasis.
4. combine with xiong huang: lessens swelling, promote new growth of tissues, rids of infections.
1. 配乳香, 活血散瘀,行氣舒筋。
2. 配穿山甲 ,活血散瘀,消腫止痛。
3. 配血竭, 活血散瘀,止痛。
4. 配雄黄, 消腫生肌,燥濕解毒。
Toxicity & Cautions毒素與禁忌 ﹕
use with care in cases of weak digestion. Not to use where there is not blood stasis, or  in cases of where boils have been ripen and ulcerated or in cases of pregnancies.
胃弱者慎服。 無淤滯 ,癰疽已潰及孕婦忌用。(Edited by: Joe Hing kwok Chu/Complementary and Alternative Healing University)

No comments:

Post a Comment